• 糖尿病肾病血液净化导管相关性血流感染病原菌分布、耐药性及Nomogram预测模型构建
  • Distribution and drug resistance of pathogenic bacteria in blood purification catheter-related bloodstream infection in diabetic nephropathy and construction of Nomogram prediction model
  • 陈鑫.糖尿病肾病血液净化导管相关性血流感染病原菌分布、耐药性及Nomogram预测模型构建[J].内科急危重症杂志,2026,32(3):245-249
    DOI:10.11768/nkjwzzzz20260308
    中文关键词:  糖尿病肾病  血液净化  导管相关性血流感染  病原菌分布  耐药性  Nomogram模型  预测
    英文关键词:Diabetic nephropathy  Blood purification  Catheter- related bloodstream infection  Pathogenic bacteria distribution  Drug resistance  Nomogram model  Prediction
    基金项目:河北省重点研发计划项目(20222101242D)
    作者单位E-mail
    陈鑫 河北省沧州市中西医结合医院实验诊断科 ydzwdh144@163.com 
    摘要点击次数: 118
    全文下载次数: 77
    中文摘要:
          摘要 目的:分析糖尿病肾病(DN)血液净化导管相关性血流感染(CRBSI)病原菌分布、耐药性,并构建CRBSI发生风险的Nomogram预测模型。方法:选取首次行血液净化治疗的DN患者185例,统计CRBSI发生率,分析CRBSI病原菌分布、耐药性,根据是否发生CRBSI分为CRBSI组和非CRBSI组,比较2组临床资料,Logistic回归分析CRBSI发生的影响因素,构建CRBSI发生风险的Nomogram预测模型并采用受试者工作特征(ROC)曲线检验其预测效能。结果:185例DN患者中,CRBSI发生率为24.32%(45/185);CRBSI组45例血液标本中共检出62株病原菌,其中革兰阳性菌、革兰阴性菌占比分别为56.45%(35/62)、43.55%(27/62);耐药性分析显示,主要革兰阳性菌金黄色葡萄球菌、表皮葡萄球菌对红霉素、克林霉素、左氧氟沙星、环丙沙星均具有不同程度耐药性,主要革兰阴性菌肺炎克雷伯菌、铜绿假单胞杆菌对氨苄西林、复方新诺明、米诺环素、美罗培南均具有不同程度耐药性;CRBSI组年龄、置管时间>7 d占比、插管次数≥3次占比、预防性应用抗菌药占比及血清C-反应蛋白(CRP)、降钙素原(PCT)、转化生长因子-β1(TGF-β1)、Smad蛋白2、Smad蛋白3水平高于非CRBSI组,自我管理能力测定量表(AHSMSRS)评分、血清25羟维生素D3[25(OH)D3]水平低于非CRBSI组 (P均<0.05);Logistic回归分析显示,年龄、置管时间、插管次数、预防性应用抗菌药、AHSMSRS评分及血清CRP、PCT、25(OH)D3、TGF-β1、Smad蛋白2、Smad蛋白3水平均为CRBSI发生的影响因素(P均<0.05);基于多因素分析结果构建CRBSI发生风险的Nomogram预测模型,ROC曲线分析显示,该模型预测CRBSI的曲线下面积为0.926,具有明显的正向净收益。结论:基于病原菌分布、耐药性及年龄、置管时间等临床资料构建DN患者血液净化CRBSI发生风险Nomogram预测模型,具有良好预测效能及临床适用性。
    英文摘要:
          Abstract Objective: To analyze the distribution and drug resistance of pathogenic bacteria in catheter-related bloodstream infection (CRBSI) among diabetic nephropathy (DN) patients undergoing blood purification, and to construct a Nomogram prediction model for the risk of CRBSI. Methods: A total of 185 DN patients receiving blood purification for the first time were enrolled. The incidence of CRBSI was calculated, and the distribution and drug resistance of CRBSI pathogenic bacteria were analyzed. Patients were divided into CRBSI group and non-CRBSI group according to the occurrence of CRBSI. Clinical data were compared between the two groups. Logistic regression analysis was used to screen the influencing factors of CRBSI, and a Nomogram prediction model for CRBSI risk was established with its predictive efficacy verified. Results: Among the 185 DN patients, the incidence rate of CRBSI was 24.32% (45/185). A total of 62 strains of pathogenic bacteria were isolated from blood samples of 45 patients in the CRBSI group, among which Gram-positive bacteria accounted for 56.45% (35/62) and Gram-negative bacteria accounted for 43.55% (27/62). Drug resistance analysis showed that the main Gram-positive bacteria including Staphylococcus aureus and Staphylococcus epidermidis presented varying degrees of drug resistance to erythromycin, clindamycin, levofloxacin and ciprofloxacin; the main Gram-negative bacteria including Klebsiella pneumoniae and Pseudomonas aeruginosa showed different levels of resistance to ampicillin, compound sulfamethoxazole, minocycline and meropenem. The CRBSI group had older age, higher proportion of catheter indwelling time (>7 days), higher proportion of intubation times (≥3 times), higher proportion of prophylactic use of antibiotics, as well as higher levels of serum C-reactive protein (CRP), procalcitonin (PCT), transforming growth factor-β1 (TGF-β1), Smad2 and Smad3 proteins, while the score of Adult Health Self-Management Behavior Rating Scale (AHSMSRS) and serum 25-hydroxyvitamin D3 [25(OH)D3] level were lower than those in the non-CRBSI group (all P< 0.05). Logistic regression analysis indicated that age, catheter indwelling time, intubation times, prophylactic use of antibiotics, AHSMSRS score, serum CRP, PCT, 25(OH)D3, TGF-β1, Smad2 and Smad3 were independent influencing factors for CRBSI (all P< 0.05). Based on the results of multivariate analysis, a Nomogram prediction model for CRBSI risk was constructed. The verification results showed that the area under the curve of the model for predicting CRBSI was 0.926, with obvious positive net benefit. Conclusion: The Nomogram prediction model for CRBSI risk in DN patients undergoing blood purification constructed based on pathogenic bacteria distribution, drug resistance and clinical indicators such as age and catheter indwelling time has good predictive performance and clinical applicability.